Masu, T., Atsukawa, M., Nakatsuka, K., Shimizu, M., Miura, D., Arai, T., . . . Iwakiri, K. (2018). Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression. PLoS One.
Citación estilo ChicagoMasu, Takushi, et al. "Anti-CD137 Monoclonal Antibody Enhances Trastuzumab-induced, Natural Killer Cell-mediated Cytotoxicity against Pancreatic Cancer Cell Lines With Low Human Epidermal Growth Factor-like Receptor 2 Expression." PLoS One 2018.
Cita MLAMasu, Takushi, et al. "Anti-CD137 Monoclonal Antibody Enhances Trastuzumab-induced, Natural Killer Cell-mediated Cytotoxicity against Pancreatic Cancer Cell Lines With Low Human Epidermal Growth Factor-like Receptor 2 Expression." PLoS One 2018.